Best of ESMO 2024 On Demand in Japan

解説【LBA29】Final overall survival (OS) in patients (pts) with newly diagnosed advanced ovarian cancer (aOC) treated with niraparib (nir) first-line (1L) maintenance: results from PRIMA/ENGOT-OV26/GOG-3012

Best of ESMO 2024 On Demand in Japan

解説【LBA29】Final overall survival (OS) in patients (pts) with newly diagnosed advanced ovarian cancer (aOC) treated with niraparib (nir) first-line (1L) maintenance: results from PRIMA/ENGOT-OV26/GOG-3012

この動画に関するお問い合わせ先

Best of ESMO 2024運営事務局 

株式会社サンプラネット 東京事業部

E-mail:jsmo-seminar@sunpla-mcv.com

 

西川 忠曉 Nishikawa Tadaaki

東京慈恵会医科大学 産婦人科学講座

0.15051412582397 秒